What are the recommended adult and pediatric dosing regimens for pralidoxime (2‑PAM) and atropine in organophosphate poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing for Organophosphate Poisoning with Atropine and Pralidoxime

For organophosphate poisoning, start atropine at 1-2 mg IV (adults) or 0.02 mg/kg (pediatrics), doubling the dose every 5 minutes until full atropinization is achieved, then maintain with continuous infusion at 10-20% of the loading dose per hour; pralidoxime should be given at 1-2 g IV (adults) or 20-50 mg/kg (pediatrics) as a loading dose, followed by continuous infusion of 400-600 mg/hr (adults) or 10-20 mg/kg/hr (pediatrics). 1

Atropine Dosing Algorithm

Adults

  • Initial bolus: 1-2 mg IV, repeated and doubled every 5 minutes until atropinization endpoints are reached 1
  • Atropinization endpoints (all must be achieved):
    • Clear chest on auscultation (no bronchorrhea)
    • Heart rate >80 bpm
    • Systolic blood pressure >80 mmHg 1
  • Maintenance infusion: 10-20% of total loading dose per hour, up to 2 mg/hr 1
  • For severe poisoning with cardiac arrest/bradycardia: Initial dose of 2-3 mg, repeated every 20-30 minutes 2

Pediatrics

  • Initial bolus: 0.02 mg/kg IV, doubled every 5 minutes until atropinization 1
  • Maintenance: Same percentage-based approach as adults

Critical point: Much higher doses than typical bradycardia treatment are required—do not hesitate to escalate aggressively. The 2023 AHA guidelines emphasize immediate administration for severe poisoning with Class 1, Level A evidence 1.

Pralidoxime (2-PAM) Dosing Algorithm

Adults

  • Loading dose: 1-2 g IV over 15-30 minutes 1, 3
  • Maintenance infusion: 400-600 mg/hr (approximately 8-10 mg/kg/hr for 70 kg patient) 1, 3
  • Target plasma level: 13-14 µg/mL (minimum therapeutic 4 µg/mL) 3

Pediatrics

  • Loading dose: 20-50 mg/kg IV (consider 50 mg/kg for severe poisoning) 1, 4
  • Maintenance infusion: 10-20 mg/kg/hr 1, 4

Important pharmacokinetic consideration: Pralidoxime has a short half-life of 74-77 minutes, and concentrations fall below therapeutic levels within 1.5 hours after a single bolus 3. Continuous infusion is superior to intermittent boluses for maintaining therapeutic levels (257.5 vs 118 minutes above 4 µg/mL) 3.

Evidence Quality and Nuances

The 2023 AHA guidelines give atropine a Class 1, Level A recommendation (strongest possible), while pralidoxime receives a Class 2a, Level A recommendation ("reasonable to use") 1. This distinction reflects that while atropine's benefit is unequivocal, pralidoxime's clinical efficacy remains somewhat controversial despite strong mechanistic rationale.

Key controversy: Recent meta-analyses show pralidoxime does not significantly reduce mortality and may increase intermediate syndrome 5, 6. However, these studies used variable dosing regimens, often below the target plasma concentrations needed for acetylcholinesterase reactivation 7. The FDA label and WHO-based dosing recommendations aim for higher sustained levels 3.

Timing matters critically: Pralidoxime must be given before "aging" of the organophosphate-acetylcholinesterase complex occurs (particularly rapid with dimethyl compounds, slower with diethyl compounds). Early administration within 12 hours may reduce intermediate syndrome 8. Once aging occurs, pralidoxime becomes ineffective 7.

Common Pitfalls to Avoid

  1. Underdosing atropine: Do not use typical bradycardia doses. Aggressive escalation is required—some patients need hundreds of milligrams over days 1

  2. Stopping atropine prematurely: Maintain infusion as long as circulating poison is present, which may require up to 10 days in severe cases 7

  3. Using succinylcholine or mivacurium: These neuromuscular blockers are metabolized by cholinesterase and are contraindicated (Class 3, Level C-LD) 1

  4. Forgetting benzodiazepines: Administer diazepam or midazolam for seizures and agitation (Class 1, Level C-LD) 1

  5. Inadequate decontamination: Remove all clothing and perform copious soap-and-water irrigation while wearing appropriate PPE 1

Carbamate Poisoning Consideration

For carbamate poisoning, atropine dosing is identical. However, pralidoxime's role is less clear—it should not be withheld when the poison class is unknown, but evidence suggests atropine alone may be sufficient 1, 9. Carbamates spontaneously dissociate from acetylcholinesterase, unlike organophosphates 1.

Practical Implementation

Prepare for prolonged therapy: Stock adequate atropine and pralidoxime supplies. A single severely poisoned patient may require 500+ mg of atropine over several days. Continuous infusions are logistically superior to repeated boluses and maintain more stable therapeutic levels 3, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.